Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 2.6 CAD 0.78% Market Closed
Market Cap: 119.5m CAD
Have any thoughts about
Theratechnologies Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-53.9
Current
-35.5
Median
5.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-53.9
=
Enterprise Value
116.1m CAD
/
Operating Cash Flow
-1.5m USD
All Countries
Close
Market Cap EV/OCF
CA
Theratechnologies Inc
TSX:TH
119.5m CAD -53.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 641.9
US
Abbvie Inc
NYSE:ABBV
316.5B USD 22.3
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 26
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.3B USD -115.9
US
Epizyme Inc
F:EPE
94.1B EUR -469.9
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.2B USD 16.7
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36B EUR -132.6
 
CA
Theratechnologies Inc
TSX:TH
Average EV/OCF: 22.1
Negative Multiple: -53.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 641.9
US
Abbvie Inc
NYSE:ABBV
22.3
US
Amgen Inc
NASDAQ:AMGN
26
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.9
AU
CSL Ltd
ASX:CSL
34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.6

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More